4-((3S,5S)-3-((tert-Butyldimethylsilyl)oxy)-5-methylcyclohex-1-en-1-yl)-3-nitropyridine

Catalog No. :
ACOXYZ623
CAS No. :
1187055-97-5
Molecular Formula :
C18H28N2O3Si
Molecular Weight :
348.52

IUPAC Name:4-((3S,5S)-3-((tert-butyldimethylsilyl)oxy)-5-methylcyclohex-1-en-1-yl)-3-nitropyridine

4-((3S,5S)-3-((tert-Butyldimethylsilyl)oxy)-5-methylcyclohex-1-en-1-yl)-3-nitropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((3S,5S)-3-((tert-Butyldimethylsilyl)oxy)-5-methylcyclohex-1-en-1-yl)-3-nitropyridine
IUPAC Name4-((3S,5S)-3-((tert-butyldimethylsilyl)oxy)-5-methylcyclohex-1-en-1-yl)-3-nitropyridine
Molecular FormulaC18H28N2O3Si
Molecular Weight348.52
SMILESC[Si](C)(C(C)(C)C)O[C@H]1C[C@@H](C)CC(C2=CC=NC=C2N(=O)=O)=C1
InChI KeyDZZFKLWTWJBVRH-ZFWWWQNUSA-N
Synonymracemic-4-((3S,5S)-3-((tert-butyldimethylsilyl)oxy)-5-methylcyclohex-1-en-1-yl)-3-nitropyridine(WXG01867);racemic-4-((3S,5S)-3-((tert-butyldimethylsilyl)oxy)-5-methylcyclohex-1-en-1-yl)-3-nitropyridine;Pyridine, 4-[(3R,5R)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5-methyl-1-cyclohexen-1-yl]-3-nitro-, rel-;tert-butyl-dimethyl-[cis-5-methyl-3-(3-nitro-4-pyridyl)cyclohex-2-en-1-yl]oxy-silane
CAS No.1187055-97-5

Synthetic Route by SureRoute

1. ACOXYZ623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOXYZ623 route product structure diagram
    ACOXYZ6231187055-97-5
Inquiry

2. ACOXYZ623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYLDE903 route compound structure diagram
    ACYLDE90323056-44-2 In Stock
  4. Then
  5. ACOXYZ623 route product structure diagram
    ACOXYZ6231187055-97-5
Inquiry

Comments (0)